Shimadzu Wins R&D 100 Award for Nexera Unified Chromatography System
News Nov 24, 2015
Shimadzu Corporation announces that it has won an R&D 100 award for the development of its Nexera UC Unified Chromatography system. The award from R&D magazine recognizes Shimadzu’s Nexera UC system as one of the 100 most technically significant new products of the year in the analytical and testing category. R&D Magazine chose the Nexera UC system because its fully automated technology opens up new analytical opportunities in many fields, including food products, drug discovery and delivery, chemicals, pharmaceuticals, and cleaning validation.
With industry-leading throughput and superior levels of sensitivity, the system eliminates the need for complicated sample pre-treatment and reduces the possibility of human error during analysis.
“We are honored that the Nexera UC system was recognized as one of the top revolutionary innovations in the world, and we are excited about its positive impact in the analytical world,” said Shuzo Maruyama, General Manager, Analytical & Measurement Instruments Division. “This award is testament to the Shimadzu engineers and developers who strive to not just make the highest quality analytical products, but to improve life for everyone by addressing today’s most crucial scientific research challenges.”
For more information on Shimadzu’s Nexera UC unified chromatography system, go to http://www.ssi.shimadzu.com/products/product.cfm?product=nexera_uc.
Rapid Removal of Arsenic From Drinking Water...By Moss!News
A moss capable of removing arsenic from contaminated water has been discovered by researchers. And it happens quickly – in just one hour, the arsenic level is so low that the water is no longer harmful for people to drink.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.